文献速递复苏、休克与脓毒症创伤与烧伤

重大出血患者复苏性主动脉腔内球囊阻断术(REBOA)需求评估:一项横断面研究

Needs assessment of resuscitative endovascular balloon occlusion of the aorta (REBOA) in patients with major haemorrhage: a cross-sectional study.
PubMed 文献 · Emerg Med J · 2021-05-26
一句话结论在挪威人群中,因出血而潜在符合REBOA适应证的患者极少(5.7/10万成人/年),且以非创伤性病因为主。

该研究基于2017-2018年血库登记和挪威创伤登记数据,回顾性识别接受≥4单位浓缩红细胞(6小时内)或符合解剖学标准或相关简明损伤定级编码伴低血压的患者共804例,经两步病历审查确定53例潜在符合REBOA适应证(5.7/10万成人/年),其中仅19例实际接受REBOA;53例中44例(83%)为非创伤性病因,42例(79%)在三級医院治疗,19例REBOA中14例(78%)因产后出血实施。结论认为潜在符合REBOA的患者数量少且多为非创伤性,排除非创伤性患者会显著低估REBOA潜在适用人群。

要点

  • 在804例重大出血患者中,仅53例潜在符合REBOA适应证,对应5.7/10万成人/年。
  • 53例潜在符合者中44例(83%)为非创伤性病因,提示仅按创伤筛选会大幅低估适用人群。
  • 53例中仅19例实际接受REBOA,19例中14例(78%)因产后出血实施。
  • 42例(79%)的潜在符合者在三级医院接受治疗,资源集中趋势明显。

适用人群与场景

  • 2017-2018年挪威人群,接受≥4单位浓缩红细胞(6小时内)且符合REBOA解剖学标准,或具有相关简明损伤定级编码并伴低血压或6小时内输血≥4单位浓缩红细胞的患者。

诊断标准与关键阈值

  • 纳入标准:6小时内接受≥4单位浓缩红细胞且符合REBOA解剖学标准,或相关简明损伤定级编码伴低血压或6小时内输血≥4单位浓缩红细胞。

处置流程与药物剂量

  • 潜在符合REBOA适应证的53例中,19例实际接受了REBOA,其中14例(78%)因产后出血实施。

研究设计与关键结果

  • 研究类型:基于血库登记和挪威创伤登记(2017-2018年)的回顾性横断面研究。
  • 共804例符合纳入标准,经两步病历审查确定53例潜在符合REBOA适应证,对应5.7/10万成人/年。
  • 53例潜在符合者中44例(83%)为非创伤性病因,42例(79%)在三級医院治疗。
  • 53例中19例实际接受REBOA,其中14例(78%)因产后出血实施。
  • 结论:潜在符合REBOA的患者数量少且多为非创伤性,排除非创伤性患者会显著低估潜在适用人群数。

证据类型、等级与局限

  • 证据类型:回顾性横断面研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,仅纳入创伤患者会显著低估潜在符合REBOA适应证的病例数;本研究中大多数潜在符合者为非创伤性病因(83%),且多在三级医院治疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) can be used as an adjunct treatment in traumatic abdominopelvic haemorrhage, ruptured abdominal aortic aneurysms, postpartum haemorrhage (PPH), gastrointestinal bleeding and iatrogenic injuries during surgery. This needs assessment study aims to determine the number of patients eligible for REBOA in a typical Norwegian population.

METHODS: This was a retrospective cross-sectional study based on data obtained from blood bank registries and the Norwegian Trauma Registry for the years 2017-2018. Patients who received ≥4 units of packed red blood cells (PRBCs) within 6 hours and met the anatomical criteria for REBOA or patients with relevant Abbreviated Injury Scale codes with concurrent hypotension or transfusion of ≥4 units of PRBCs within 6 hours were identified. A detailed two-step chart review was performed to identify potentially eligible REBOA candidates. Descriptive data were collected and compared between subgroups using non-parametric tests for statistical significance.

RESULTS: Of 804 patients eligible for inclusion, 53 patients were regarded as potentially REBOA eligible (corresponding to 5.7 per 100 000 adult population/year). Of these, 19 actually received REBOA. Among the identified eligible patients, 44 (83%) had a non-traumatic aetiology. Forty-two patients (79%) were treated at a tertiary care hospital. Fourteen (78%) of the REBOA procedures were due to PPH.

CONCLUSION: The number of patients potentially eligible for REBOA after haemorrhage is low, and most cases are non-traumatic. Most patients were treated at a tertiary care hospital. The exclusion of non-traumatic patients results in a substantial underestimation of the number of potentially REBOA-eligible patients.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Godø BN, Brede JR, Krüger AJ, et al. Needs assessment of resuscitative endovascular balloon occlusion of the aorta (REBOA) in patients with major haemorrhage: a cross-sectional study. Emerg Med J. 2021. PMID: 34039645. doi:10.1136/emermed-2020-210808

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。